Next speaker
Albert Garcia-Romeu, PhD
Assistant Professor of Psychiatry and Behavioral Sciences @JHPsychedelics Johns Hopkins University School of Medicine #LymeDiseaseAwarenessMonth
Albert Garcia-Romeu, PhD
The war on drugs has made it difficult to study these compounds. Although more recently there is more human research. #LymeDiseaseAwarenessMonth
Albert Garcia-Romeu, PhD
Earlier studies have shown improvements in certain conditions. They are just beginning to look at Lyme disease #LymeDiseaseAwarenessMonth
Albert Garcia-Romeu, PhD
The majority of patients upon follow-up report persisting positive effects from the psilocybin trials. #LymeDiseaseAwarenessMonth
Albert Garcia-Romeu, PhD
Up to one year later patients are reporting benefits especially in their perception of well-being.
Warning: about 50% of patients have adverse events when the dose is too high. #LymeDiseaseAwarenessMonth
Albert Garcia-Romeu, PhD
The patients who got the most out of the dosing sessions @JHPsychedelics had a support group.
Albert Garcia-Romeu, PhD
How does psilocybin work? Appears to be changes in serotonin receptors.
Albert Garcia-Romeu, PhD
These drugs also have anti-inflammatory properties and may be helpful in patients with post-treatment Lyme disease. Currently recruiting 20 patients for the first trial. #LymeDiseaseAwarenessMonth
Albert Garcia-Romeu, PhD
This is the time line of the #LymeDisease study and how they will be measuring outcomes.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
In 14 days the California Board of Pharmacy (BOP) could vote to restrict a long list of legal and widely used natural compounds. This discussion and potential vote will take place at their 9/12 public board meeting.
Learn How You Can Help 🧵 1/
1. Sign and share the petition today! (or link in bio)
2. Alert your representatives: Visit to find them. Not in California? No problem. You can still contact Gov. Newsom to defend your California neighbors! 2/change.org/stopthebop findyourrep.legislature.ca.gov
3. Call or email The BOP your objections: 916-518-3100 or debbie.damoth@dca.ca.gov 4. Attend the 9/12 Board Meeting via Webex or in person and exercise your 1st amendment right by giving a public comment! Access links and instructions will be available at stopthebop.com/actnow
Next is Dr. @aucott_john on Lyme disease and infection associated chronic illness. Lessons from COVID Long Haulers and ME/CFS.
Infection associated illness is not new. #LymeDiseaseAwarenessMonth
Dr @aucott_john quickly noticed the symptoms of #LongCOVID were very similar to #LongLyme. Can occur in patients with mild illnesss. Something similar in how these diseases are affecting humans (P.S. Long-haul does not occur post-flu.) #LymeDiseaseAwarenessMonth
Patients with chronic illnesses are often disbelieved. It is difficult as there are no diagnostic tests to prove "Long haul" is real.
Jeff says they were able to present the @liv_lyme@TicktrackerAPP to the The National Association and County and City Health Officials (NACCHO) and the Centers for Disease Control and Prevention (CDC) during Vector Week. #LymeDiseaseAwarenessMonth
Since it's launch in 2018 @TicktrackerAPP has had over 8,000 submissions. Submissions peak in May-June. American dog tick was number one tick identified. #LymeDiseaseAwarenessMonth
Dr. Rajadas, a pharmacologist by training, finding doxycycline is not clearing infection in the lab. However, mitomycin & azlocillin are working well. Prefers fewest number of molecules as treatment option (1 or 2 at most). #LymeDiseaseAwarenessMonth
Rajadas finding TLR2 interaction in both Borrelia and SARS-Cov-2 surface proteins, also elevation of quinolinic acid. #LymeDiseaseAwarenessMonth